{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:22:33Z","timestamp":1787772153298,"version":"build-2784847793"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Melatonin is an important hormone secreted from the pineal gland that mediates several biological functions in humans through circadian rhythm. The multimodal properties of melatonin when administered systemically have generated a lot of interest among researchers. The anticancer properties of melatonin per se and its importance in cancer patients when used as an adjunct to ongoing chemotherapy and radiotherapy have led to tremendous research in animals and humans with encouraging results. The present write-up discusses the current evidence of using melatonin as an adjunct in hormone-dependent and hormone-independent cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijc.ijc_1197_20","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T06:28:30Z","timestamp":1712730510000},"page":"288-294","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Anticancer properties of melatonin and its role as an adjuvant in cancer treatment"],"prefix":"10.4103","volume":"59","author":[{"given":"Abhijit","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-23-20240828","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/1570159X14666161228122115","article-title":"Melatonin: Pharmacology, functions and therapeutic benefits","volume":"15","author":"Tordjman","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"R3-23-20240828","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1210\/er.2018-00084","article-title":"Melatonin as a Hormone: New Physiological and Clinical Insights","volume":"39","author":"Cipolla-Neto","year":"2018","journal-title":"Endocr Rev"},{"key":"R4-23-20240828","first-page":"2747","article-title":"Role of melatonin in cancer treatment","volume":"32","author":"Cutando","year":"2012","journal-title":"Anticancer Res"},{"key":"R5-23-20240828","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1534735408322846","article-title":"Therapeutic actions of melatonin in cancer: Possible mechanisms","volume":"7","author":"Srinivasan","year":"2008","journal-title":"Integr Cancer Ther"},{"key":"R6-23-20240828","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.7314\/APJCP.2014.15.11.4405","article-title":"Oxidative stress and antioxidants in disease and cancer: A review","volume":"15","author":"Gupta","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R7-23-20240828","doi-asserted-by":"crossref","first-page":"4868417","DOI":"10.1155\/2018\/4868417","article-title":"Effect of natural compounds on NK cell activation","volume":"2018","author":"Grudzien","year":"2018","journal-title":"J Immunol Res"},{"key":"R8-23-20240828","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1016\/j.semcancer.2015.09.007","article-title":"Designing a broad-spectrum integrative approach for cancer prevention and treatment","volume":"35","author":"Block","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"R9-23-20240828","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11010-019-03617-5","article-title":"Melatonin and its ubiquitous anticancer effects","volume":"462","author":"Bhattacharya","year":"2019","journal-title":"Mol Cell Biochem"},{"key":"R10-23-20240828","doi-asserted-by":"crossref","first-page":"39896","DOI":"10.18632\/oncotarget.16379","article-title":"Melatonin for the prevention and treatment of cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"R11-23-20240828","doi-asserted-by":"crossref","first-page":"3271948","DOI":"10.1155\/2018\/3271948","article-title":"Melatonin: An anti-tumor agent in hormone-dependent cancers","volume":"2018","author":"Men\u00e9ndez-Men\u00e9ndez","year":"2018","journal-title":"Int J Endocrinol"},{"key":"R12-23-20240828","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/jmp.JMP_9_17","article-title":"Modulation of radiation-induced base excision repair pathway gene expression by melatonin","volume":"42","author":"Rezapoor","year":"2017","journal-title":"J Med Phys"},{"key":"R13-23-20240828","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1002\/jcb.28832","article-title":"Melatonin is an appropriate candidate for breast cancer treatment: Based on known molecular mechanisms","volume":"120","author":"Amin","year":"2019","journal-title":"J Cell Biochem"},{"key":"R14-23-20240828","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1034\/j.1600-079X.2003.00074.x","article-title":"Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype","volume":"35","author":"Shiu","year":"2003","journal-title":"J Pineal Res"},{"key":"R15-23-20240828","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/carcin\/bgx054","article-title":"Melatonin as a promising agent to treat ovarian cancer: Molecular mechanisms","volume":"38","author":"Chuffa","year":"2017","journal-title":"Carcinogenesis"},{"key":"R16-23-20240828","doi-asserted-by":"crossref","first-page":"21670","DOI":"10.1002\/jcp.28865","article-title":"Melatonin: A new inhibitor agent for cervical cancer treatment","volume":"234","author":"Shafabakhsh","year":"2019","journal-title":"J Cell Physiol"},{"key":"R17-23-20240828","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/1389450120666190927123746","article-title":"Molecular and biological functions of melatonin in endometrial cancer","volume":"21","author":"Dana","year":"2020","journal-title":"Curr Drug Targets"},{"key":"R18-23-20240828","doi-asserted-by":"crossref","first-page":"90545","DOI":"10.18632\/oncotarget.20079","article-title":"Melatonin as a potential inhibitory agent in head and neck cancer","volume":"8","author":"Yeh","year":"2017","journal-title":"Oncotarget"},{"key":"R19-23-20240828","doi-asserted-by":"crossref","first-page":"G623","DOI":"10.1152\/ajpgi.00118.2011","article-title":"Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: Its synthesis is reduced favoring cholangiocarcinoma growth","volume":"301","author":"Han","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R20-23-20240828","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-079X.2012.00975.x","article-title":"Melatonin enhances thapsigargin-induced apoptosis through reactive oxygen species-mediated upregulation of CCAAT-enhancer-binding protein homologous protein in human renal cancer cells","volume":"53","author":"Min","year":"2012","journal-title":"J Pineal Res"},{"key":"R21-23-20240828","first-page":"e1011327","article-title":"Melatonin inhibits the migration of human lung adenocarcinoma a549 cell lines involving JNK\/MAPK pathway","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"R22-23-20240828","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1159\/000438587","article-title":"Melatonin induces cell apoptosis in AGS cells through the activation of JNK and P38 MAPK and the suppression of nuclear factor-kappa B: A novel therapeutic implication for gastric cancer","volume":"37","author":"Li","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"R23-23-20240828","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1002\/jcp.27372","article-title":"Melatonin and pancreatic cancer: Current knowledge and future perspectives","volume":"234","author":"Tamtaji","year":"2019","journal-title":"J Cell Physiol"},{"key":"R24-23-20240828","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jpi.12119","article-title":"Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells","volume":"56","author":"Hong","year":"2014","journal-title":"J Pineal Res"},{"key":"R25-23-20240828","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jid.2017.10.025","article-title":"Melatonin: A cutaneous perspective on its production, metabolism, and functions","volume":"138","author":"Slominski","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R26-23-20240828","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/ijms18040843","article-title":"Melatonin, a full service anti-cancer agent: Inhibition of initiation, progression and metastasis","volume":"18","author":"Reiter","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R27-23-20240828","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/onc.2011.469","article-title":"Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation","volume":"31","author":"Santoro","year":"2012","journal-title":"Oncogene"},{"key":"R28-23-20240828","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-079X.2009.00682.x","article-title":"Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: Therapeutic implications for prostate cancer","volume":"47","author":"Joo","year":"2009","journal-title":"J Pineal Res"},{"key":"R29-23-20240828","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/molecules23030518","article-title":"Melatonin and cancer hallmarks","volume":"23","author":"Talib","year":"2018","journal-title":"Molecules"},{"key":"R30-23-20240828","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s00432-020-03292-w","article-title":"Melatonin: An endogenous miraculous indolamine, fights against cancer progression","volume":"146","author":"Samanta","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"R31-23-20240828","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.2174\/092986712801661013","article-title":"Melatonin, a natural programmed cell death inducer in cancer","volume":"19","author":"S\u00e1nchez-Hidalgo","year":"2012","journal-title":"Curr Med Chem"},{"key":"R32-23-20240828","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1002\/jcp.27391","article-title":"Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment","volume":"234","author":"Farhood","year":"2019","journal-title":"J Cell Physiol"},{"key":"R33-23-20240828","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","article-title":"The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism","volume":"356","author":"Lu","year":"2015","journal-title":"Cancer Lett"},{"key":"R34-23-20240828","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-079X.2012.00973.x","article-title":"Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells","volume":"53","author":"Wang","year":"2012","journal-title":"J Pineal Res"},{"key":"R36-23-20240828","doi-asserted-by":"crossref","first-page":"e12514","DOI":"10.1111\/jpi.12514","article-title":"Melatonin and its metabolites vs oxidative stress: From individual actions to collective protection","volume":"65","author":"Galano","year":"2018","journal-title":"J Pineal Res"},{"key":"R37-23-20240828","first-page":"17","article-title":"Ocular input for human melatonin regulation: Relevance to breast cancer","volume":"23","author":"Glickman","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"key":"R38-23-20240828","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/07420528.2012.667859","article-title":"The endogenous melatonin (MT) signal facilitates re-entrainment of the circadian system to light-induced phase advances by acting upon MT2 receptors","volume":"29","author":"Pfeffer","year":"2012","journal-title":"Chronobiol Int"},{"key":"R39-23-20240828","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1749-6632.2000.tb05403.x","article-title":"Gene regulation by melatonin","volume":"917","author":"Carlberg","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R40-23-20240828","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/jcp.27259","article-title":"Adjuvant chemotherapy with melatonin for targeting human cancers: A review","volume":"234","author":"Najafi","year":"2019","journal-title":"J Cell Physiol"},{"key":"R41-23-20240828","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00280-017-3441-3","article-title":"Participation of MT3 melatonin receptors in the synergistic effect of melatonin on cytotoxic and apoptotic actions evoked by chemotherapeutics","volume":"80","author":"Pariente","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"R42-23-20240828","doi-asserted-by":"crossref","first-page":"38294","DOI":"10.1074\/jbc.M403140200","article-title":"Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin","volume":"279","author":"del R\u00edo","year":"2004","journal-title":"J Biol Chem"},{"key":"R43-23-20240828","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jpi.12052","article-title":"Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1\u03b1","volume":"55","author":"Zhang","year":"2013","journal-title":"J Pineal Res"},{"key":"R44-23-20240828","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.taap.2017.09.022","article-title":"Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence","volume":"335","author":"Goradel","year":"2017","journal-title":"Toxicol Appl Pharmacol"},{"key":"R45-23-20240828","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.2147\/OTT.S174100","article-title":"Therapeutic strategies of melatonin in cancer patients: A systematic review and meta-analysis","volume":"11","author":"Wang","year":"2018","journal-title":"Onco Targets Ther"},{"key":"R46-23-20240828","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.3390\/ijms14048638","article-title":"Melatonin: Buffering the immune system","volume":"14","author":"Carrillo-Vico","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R47-23-20240828","first-page":"373","article-title":"Melatonin and cancer","volume":"7","author":"Zamfir Chiru","year":"2014","journal-title":"J Med Life"},{"key":"R48-23-20240828","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7150\/oncm.25566","article-title":"The role of melatonin in cancer development","volume":"3","author":"Liu","year":"2018","journal-title":"Oncomedicine"},{"key":"R49-23-20240828","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3389\/fphar.2018.01086","article-title":"Promising antineoplastic actions of melatonin","volume":"9","author":"Favero","year":"2018","journal-title":"Front Pharmacol"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_1197_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:31:18Z","timestamp":1787769078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_1197_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_1197_20","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}